From anti-PD1/L1 inhibitors to new immunotherapies

Thierry Berghmans (Belgium)

Source: New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine
Number: 13

Slide presentationPDF journal article, handout or slidesWebcast

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Thierry Berghmans (Belgium). From anti-PD1/L1 inhibitors to new immunotherapies. New biomarkers, molecules and therapeutic sequences for non small cell lung carcinoma in the era of precision medicine

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: